Rocket Pharmaceuticals, Inc.
Pharmaceutical company · New York, United States · Nasdaq: RCKT
Rocket Pharmaceuticals, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker RCKT. It has received 100 US government small-business research awards (SBIR/STTR) from health agencies, $38 million in total, most recently in 2005. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2011.
Rocket Pharmaceuticals at a glance
What does Rocket Pharmaceuticals do?
US government research funding
100 SBIR/STTR small-business research awards from US health agencies, $38.4 million in total (1997 to 2005).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $23.6 million sold (2011).
Frequently asked questions about Rocket Pharmaceuticals
Where is Rocket Pharmaceuticals headquartered?
Rocket Pharmaceuticals, Inc. is headquartered in New York, United States.
What does Rocket Pharmaceuticals do?
Rocket Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Rocket Pharmaceuticals a public company?
Yes. Rocket Pharmaceuticals, Inc. trades on Nasdaq under the ticker RCKT.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
- SELLAS Life Sciences Group, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.